Hemodynamics and Vasopressor Support During Targeted Temperature Management at 33°C Versus 36°C After Out-of-Hospital Cardiac Arrest: A Post Hoc Study of the Target Temperature Management Trial*

Objective:To investigate the hemodynamic profile associated with different target temperatures and to assess the prognostic implication of inotropic/vasopressor support and mean arterial pressure after out-of-hospital cardiac arrest. There is a lack of information how different target temperatures may affect hemodynamics. Design:Post hoc analysis of a prospective randomized study. Setting:Thirthy-six ICUs in 10 countries. Patients:Nine hundred twenty patients (97%) with available vasopressor data out of 950 patients from the Target Temperature Management trial randomly assigned patients to a targeted temperature management at 33°C or 36°C. Interventions:None. Measurements and Main Results:Mean arterial pressure, heart rate, and lactate were registered at prespecified time points. The population was stratified according to cardiovascular Sequential Organ Failure Assessment = 4 defining the high vasopressor group and cardiovascular Sequential Organ Failure Assessment less than or equal to 3 defining the low vasopressor group. The targeted temperature management 33 (TTM33) group had a hemodynamic profile with lower heart rate (–7.0 min–1 [95% confidence limit, –8.7, –5.1]; pgroup < 0.0001), similar mean arterial pressure (–1.1 mm Hg [95% confidence limit, –2.3, 0.2]; pgroup = 0.10), and increased lactate (0.6 mmol/L [95% confidence limit, 0.3, 0.8]; pgroup < 0.0001) compared with the targeted temperature management 36 (TTM36) group. A cardiovascular Sequential Organ Failure Assessment score = 4 was recorded in 54% versus 45%, p = 0.03 in the TTM33 and the TTM36 group, respectively. The high vasopressor group carried a 53% mortality rate when compared with a 34% in the low vasopressor group, plog-rank less than 0.0001, with an adjusted hazard ratio of 1.38 (95% CI, 1.11–1.71; p = 0.004). There was no interaction between vasopressor group and allocated target temperature group (p = 0.40). An inverse relationship between mean arterial pressure and mortality was identified (p = 0.0008). Conclusions:Targeted temperature management at 33°C was associated with hemodynamic alterations with decreased heart rate, elevated levels of lactate, and need for increased vasopressor support compared with targeted temperature management at 36°C. Low mean arterial pressure and need for high doses of vasopressors were associated with increased mortality independent of allocated targeted temperature management.

[1]  L. Køber,et al.  Hemodynamics and vasopressor support in therapeutic hypothermia after cardiac arrest: prognostic implications. , 2014, Resuscitation.

[2]  M. Wise,et al.  Targeted temperature management at 33°C versus 36°C after cardiac arrest. , 2013, The New England journal of medicine.

[3]  B. Abella,et al.  Higher mean arterial pressure with or without vasoactive agents is associated with increased survival and better neurological outcomes in comatose survivors of cardiac arrest , 2013, Intensive Care Medicine.

[4]  J. Smith,et al.  Procalcitonin after cardiac arrest - an indicator of severity of illness, ischemia-reperfusion injury and outcome. , 2013, Resuscitation.

[5]  A. Rossetti,et al.  Serum procalcitonin as a marker of post-cardiac arrest syndrome and long-term neurological recovery, but not of early-onset infections, in comatose post-anoxic patients treated with therapeutic hypothermia. , 2013, Resuscitation.

[6]  J. Parrillo,et al.  Therapeutic hypothermia and vasopressor dependency after cardiac arrest. , 2013, Resuscitation.

[7]  P. Klepstad,et al.  Effects of Hypothermia on the Disposition of Morphine, Midazolam, Fentanyl, and Propofol in Intensive Care Unit Patients , 2013, Drug Metabolism and Disposition.

[8]  S. Lydersen,et al.  Propofol and remifentanil versus midazolam and fentanyl for sedation during therapeutic hypothermia after cardiac arrest: a randomised trial , 2012, Intensive Care Medicine.

[9]  M. Kuiper,et al.  Target Temperature Management after out-of-hospital cardiac arrest--a randomized, parallel-group, assessor-blinded clinical trial--rationale and design. , 2012, American heart journal.

[10]  A. Cariou,et al.  Postcardiac arrest syndrome: from immediate resuscitation to long-term outcome , 2011, Annals of intensive care.

[11]  C. Callaway,et al.  An early, novel illness severity score to predict outcome after cardiac arrest. , 2011, Resuscitation.

[12]  Vinay M Nadkarni,et al.  Part 14: Pediatric Advanced Life Support , 2010 .

[13]  R. Neumar,et al.  Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. , 2010, Circulation.

[14]  A. Egberts,et al.  Effects of Hypothermia on Pharmacokinetics and Pharmacodynamics , 2010, Clinical pharmacokinetics.

[15]  R. Neumar,et al.  Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication: A scientific statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; , 2009, International emergency nursing.

[16]  L. Rasmussen,et al.  The impact of therapeutic hypothermia on neurological function and quality of life after cardiac arrest. , 2009, Resuscitation.

[17]  R. Neumar,et al.  Consensus Process , 2022 .

[18]  J. Parrillo,et al.  Early arterial hypotension is common in the post-cardiac arrest syndrome and associated with increased in-hospital mortality. , 2008, Resuscitation.

[19]  P. Kochanek,et al.  Effects of hypothermia on drug disposition, metabolism, and response: A focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system , 2007, Critical care medicine.

[20]  J. Nolan,et al.  Recommended guidelines for reviewing, reporting, and conducting research on post-resuscitation care: the Utstein style. , 2005, Resuscitation.

[21]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[22]  J. Chiche,et al.  Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. , 2002, Journal of the American College of Cardiology.

[23]  Karen Smith,et al.  Treatment of Comatose Survivors of Out-of-hospital Cardiac Arrest With Induced Hypothermia , 2003 .

[24]  S. Bernard,et al.  Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. , 2002, The New England journal of medicine.

[25]  G. Steinberg,et al.  Mild Hypothermia Reduces Apoptosis of Mouse Neurons In vitro Early in the Cascade , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  A Whitelaw,et al.  Cardiovascular Changes During Mild Therapeutic Hypothermia and Rewarming in Infants With Hypoxic–Ischemic Encephalopathy , 2000, Pediatrics.

[27]  D. Reich,et al.  Cerebral metabolic suppression during hypothermic circulatory arrest in humans. , 1999, The Annals of thoracic surgery.

[28]  S. Horvath,et al.  Urinary responses to cold temperature during water immersion. , 1985, The American journal of physiology.

[29]  P. Cryer,et al.  Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. , 1980, The Journal of clinical investigation.

[30]  B. Jennett,et al.  ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale , 1975, The Lancet.

[31]  Foss Mv MANAGEMENT OF VIRUS HEPATITIS. , 1964 .

[32]  J. Rankin Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis , 1957, Scottish medical journal.

[33]  D A HOLADAY,et al.  Cerebral blood flow and cerebral oxygen consumption during hypothermia. , 1954, The American journal of physiology.